https://www.zonebourse.com/cours/action/THERAVANCE-BIOPHARMA-INC-16501278/actualite/Theravance-Biopharma-annonce-les-resultats-de-l-etude-de-phase-4-YUPELRIMD-PIFR-2-chez-les-patie-45680666/?utm_source=telegram&utm_medium=social&utm_campaign=share